MetaCap

Tevogen Statistics

NASDAQ: TVGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

5.90-0.40 (-6.35%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Tevogen by the numbers

Tevogen has a market capitalization of $405.2 million based on 68.68M shares outstanding. With trailing EPS of $-7.01, Tevogen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.7% below its 50-day average and 20.7% below its 200-day average.

Average daily trading volume is 7.94K shares, or about $46,864 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TVGN valuation vs. peer median

TVGN compared with the median of 8 peer companies
MetricTVGNPeer medianDifference
Market cap$405.20M$423.78M-4%
Avg. volume7.94K1.33M-99%

Peer median across 8 companies: TECX, CADL, PROK, IRLA, FENC, ALEC, RGNX, SANA.

Valuation

Price and trading

Previous close
6.30
Open
6.35
Day range
5.72 – 6.35
52-week range
3.64 – 24.90
52-week change
-73.84%
Beta
—
Volume
9.35K

Dividends and events

Annual dividend
None
Next earnings date
Nov 16, 2026

Additional statistics

Market Cap
405.20M
Eps
-7.01
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
24.90
Week52 Low
3.64
Avg Volume
7,943.00
Shares Outstanding
68.68M
Ma50
6.61
Ma200
7.44
Earnings Date
Nov 16, 2026
Pct From52w High
-76.31%
Pct From52w Low
62.27%

Related